• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MediTek parent sees '95 results soar

Article

The corporate parent of imaging services firm MediTek Health postedsharply higher sales and income for its 1995 fiscal year (end-October).Heico of Hollywood, FL, said the good news was due to gains inMediTek's business as well as that of Heico's

The corporate parent of imaging services firm MediTek Health postedsharply higher sales and income for its 1995 fiscal year (end-October).Heico of Hollywood, FL, said the good news was due to gains inMediTek's business as well as that of Heico's aerospace operations.

For the year, Heico enjoyed revenues of $40.4 million, up 25%from $32.4 million in 1994. Net income for 1995 was $2.7 million,up 83% over the $1.5 million registered last year, a figure thatdoes not include an accounting change that increased 1994 netincome by $381,000.

For the fourth quarter of 1995, Heico had revenues of $10.7million and net income of $753,000, compared to revenues of $9million and net income of $532,000 in the same period a year ago.

Heico said MediTek's operating income increased 54% over lastyear, while sales gained 12%.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.